000 01708 a2200505 4500
005 20250512095037.0
264 0 _c19700205
008 197002s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.1969.tb46372.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrown, R R
245 0 0 _aTryptophan metabolism as affected by anovulatory agents.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cSep 1969
300 _a44-56 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAminohippuric Acids
_xurine
650 0 4 _aChlorotrianisene
_xpharmacology
650 0 4 _aDiethylstilbestrol
_xpharmacology
650 0 4 _aEstrogens
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIsoniazid
_xpharmacology
650 0 4 _aKynurenine
_xmetabolism
650 0 4 _aMale
650 0 4 _aMenstruation
650 0 4 _aMestranol
_xpharmacology
650 0 4 _aNiacinamide
_xmetabolism
650 0 4 _aNicotinic Acids
_xmetabolism
650 0 4 _aNorethynodrel
_xpharmacology
650 0 4 _aOvulation
_xdrug effects
650 0 4 _aPregnancy
650 0 4 _aProgesterone
_xpharmacology
650 0 4 _aPyridoxine
_xpharmacology
650 0 4 _aScleroderma, Systemic
_xurine
650 0 4 _aTryptophan
_xmetabolism
650 0 4 _aUrinary Bladder Neoplasms
_xurine
650 0 4 _aVitamin B 6 Deficiency
_xurine
650 0 4 _aXanthurenates
_xurine
700 1 _aRose, D P
700 1 _aPrice, J M
700 1 _aWolf, H
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 166
_gno. 1
_gp. 44-56
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.1969.tb46372.x
_zAvailable from publisher's website
999 _c4248590
_d4248590